Literature DB >> 10590138

cis expression of the F12 human immunodeficiency virus (HIV) Nef allele transforms the highly productive NL4-3 HIV type 1 to a replication-defective strain: involvement of both Env gp41 and CD4 intracytoplasmic tails.

E Olivetta1, K Pugliese, R Bona, P D'Aloja, F Ferrantelli, A C Santarcangelo, G Mattia, P Verani, M Federico.   

Abstract

F12 human immunodeficiency virus type 1 (HIV-1) nef is a naturally occurring nef mutant cloned from the provirus of a nonproductive, nondefective, and interfering HIV-1 variant (F12-HIV). We have already shown that cells stably transfected with a vector expressing the F12-HIV nef allele do not downregulate CD4 receptors and, more peculiarly, become resistant to the replication of wild type (wt) HIV. In order to investigate the mechanism of action of such an HIV inhibition, the F12-HIV nef gene was expressed in the context of the NL4-3 HIV-1 infectious molecular clone by replacing the wt nef gene (NL4-3/chi). Through this experimental approach we established the following. First, NL4-3/chi and nef-defective (Deltanef) NL4-3 viral particles behave very similarly in terms of viral entry and HIV protein production during the first replicative cycle. Second, no viral particles were produced from cells infected with NL4-3/chi virions, whatever the multiplicity of infection used. The viral inhibition apparently occurs at level of viral assembling and/or release. Third, this block could not be relieved by in-trans expression of wt nef. Finally, NL4-3/chi reverts to a producer HIV strain when F12-HIV Nef is deprived of its myristoyl residue. Through a CD4 downregulation competition assay, we demonstrated that F12-HIV Nef protein potently inhibits the CD4 downregulation induced by wt Nef. Moreover, we observed a redistribution of CD4 receptors at the cell margin induced by F12-HIV Nef. These observations strongly suggest that F12-HIV Nef maintains the ability to interact with the intracytoplasmic tail of the CD4 receptor molecule. Remarkably, we distinguished the intracytoplasmic tails of Env gp41 and CD4 as, respectively, viral and cellular targets of the F12-HIV Nef-induced viral retention. For the first time, the inhibition of the viral life cycle by means of in-cis expression of a Nef mutant is here reported. Delineation of the F12-HIV Nef mechanism of action may offer additional approaches to interference with the propagation of HIV infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10590138      PMCID: PMC111560          DOI: 10.1128/jvi.74.1.483-492.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Transformation of mammalian cells with genes from procaryotes and eucaryotes.

Authors:  M Wigler; R Sweet; G K Sim; B Wold; A Pellicer; E Lacy; T Maniatis; S Silverstein; R Axel
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

2.  Roles for endocytosis in lentiviral replication.

Authors:  M Marsh; A Pelchen-Matthews; J A Hoxie
Journal:  Trends Cell Biol       Date:  1997-01       Impact factor: 20.808

3.  The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes.

Authors:  M E Greenberg; A J Iafrate; J Skowronski
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

4.  The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglobulin gene family.

Authors:  P J Maddon; D R Littman; M Godfrey; D E Maddon; L Chess; R Axel
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

5.  Human immunodeficiency virus (HIV)-resistant CD4+ UT-7 megakaryocytic human cell line becomes highly HIV-1 and HIV-2 susceptible upon CXCR4 transfection: induction of cell differentiation by HIV-1 infection.

Authors:  M Baiocchi; E Olivetta; C Chelucci; A C Santarcangelo; R Bona; P d'Aloja; U Testa; N Komatsu; P Verani; M Federico
Journal:  Blood       Date:  1997-04-15       Impact factor: 22.113

6.  Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection.

Authors:  F Kirchhoff; T C Greenough; D B Brettler; J L Sullivan; R C Desrosiers
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

7.  Mutational analysis of the human immunodeficiency virus type 1 Eli Nef function.

Authors:  E Zazopoulos; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

8.  HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.

Authors:  K L Collins; B K Chen; S A Kalams; B D Walker; D Baltimore
Journal:  Nature       Date:  1998-01-22       Impact factor: 49.962

9.  Human immunodeficiency virus infection of human-PBL-SCID mice.

Authors:  D E Mosier; R J Gulizia; S M Baird; D B Wilson; D H Spector; S A Spector
Journal:  Science       Date:  1991-02-15       Impact factor: 47.728

10.  The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages.

Authors:  M D Miller; M T Warmerdam; I Gaston; W C Greene; M B Feinberg
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Gene therapy for HIV.

Authors:  A M Lever
Journal:  Sex Transm Infect       Date:  2001-04       Impact factor: 3.519

2.  The membrane-proximal tyrosine-based sorting signal of human immunodeficiency virus type 1 gp41 is required for optimal viral infectivity.

Authors:  John R Day; Carsten Münk; John C Guatelli
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

3.  The functional CD8 T cell response to HIV becomes type-specific in progressive disease.

Authors:  Sang Kyung Lee; Zhan Xu; Judy Lieberman; Premlata Shankar
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

4.  Nef from human immunodeficiency virus type 1(F12) inhibits viral production and infectivity.

Authors:  O T Fackler; P d'Aloja; A S Baur; M Federico; B M Peterlin
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

5.  Nef binds p6* in GagPol during replication of human immunodeficiency virus type 1.

Authors:  Luciana J Costa; Yong-Hui Zheng; Jerica Sabotic; Johnson Mak; Oliver T Fackler; B Matija Peterlin
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

6.  Virological consequences of early events following cell-cell contact between human immunodeficiency virus type 1-infected and uninfected CD4+ cells.

Authors:  Eliana Ruggiero; Roberta Bona; Claudia Muratori; Maurizio Federico
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

7.  Macrophages transmit human immunodeficiency virus type 1 products to CD4-negative cells: involvement of matrix metalloproteinase 9.

Authors:  Claudia Muratori; Antonella Sistigu; Eliana Ruggiero; Mario Falchi; Ilaria Bacigalupo; Clelia Palladino; Elena Toschi; Maurizio Federico
Journal:  J Virol       Date:  2007-06-20       Impact factor: 5.103

8.  Exogenous HIV-1 Nef upsets the IFN-γ-induced impairment of human intestinal epithelial integrity.

Authors:  Maria Giovanna Quaranta; Olimpia Vincentini; Cristina Felli; Francesca Spadaro; Marco Silano; Diego Moricoli; Luciana Giordani; Marina Viora
Journal:  PLoS One       Date:  2011-08-08       Impact factor: 3.240

9.  HIV-1 nef suppression by virally encoded microRNA.

Authors:  Shinya Omoto; Masafumi Ito; Yutaka Tsutsumi; Yuko Ichikawa; Harumi Okuyama; Ebiamadon Andi Brisibe; Nitin K Saksena; Yoichi R Fujii
Journal:  Retrovirology       Date:  2004-12-15       Impact factor: 4.602

10.  On the role of four small hairpins in the HIV-1 RNA genome.

Authors:  Stefanie A Knoepfel; Ben Berkhout
Journal:  RNA Biol       Date:  2013-03-27       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.